基于CT或PET/CT的栖息地成像应用进展系统综述
本系统综述纳入21项研究共7363例患者,分析基于CT或PET/CT的栖息地成像在肿瘤诊断与治疗中的应用。结果显示其在评估治疗反应、预测预后及揭示肿瘤病理分子特征方面具有初步潜力,但证据质量低至中等,方法学异质性大。
要点
- 栖息地成像可显示肿瘤内异质性,辅助评估治疗反应与预后
- 目前证据多为回顾性研究,临床应用前需前瞻性验证
- 图像采集、分割方法及栖息地定义在各研究间差异明显
核心结论
- 基于CT或PET/CT的栖息地成像在评估治疗反应、预测预后及揭示肿瘤病理与分子特征方面展现初步潜力
- 当前证据质量低至中等且存在偏倚风险,方法学异质性较大,整体处于相对早期阶段
研究设计与样本
- 系统综述,检索PubMed、Embase、Web of Science及Cochrane Library数据库
- 共纳入21项研究,包含7363例患者,研究质量采用放射组学质量评分(RQS)评估
- 所有纳入研究均为回顾性设计,平均RQS评分为15.71±3.06
- 纳入癌种包括肺(47.6%)、头颈(14.3%)、肾(14.3%)、胃肠道(9.5%)、卵巢(9.5%)及肝(4.8%)
诊断标准与关键数值
- 各研究提取的放射组学特征数量范围为41至12838个
- 常见局限性包括缺乏扫描仪模拟研究、前瞻性验证、成本效益分析及数据/代码共享
临床应用与阅片要点
- 阅片时需注意栖息地成像目前不能单独作为临床决策依据,应结合常规影像与临床信息
- 不同研究的图像采集、分割方法和栖息地定义不一致,解读文献结果时需审慎判断适用性
局限性
- 所有纳入研究均为回顾性设计,缺乏前瞻性验证
- 研究间在图像采集、分割方法及栖息地定义方面存在显著异质性
- 缺乏扫描仪模拟研究及成本效益分析,且数据与代码共享不足
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Habitat imaging (HI) enables the identification of tumor heterogeneity and characterization of the tumor microenvironment. Although HI based on MRI is well-established, its implementation using CT or PET/CT remains nascent and underexplored.
OBJECTIVE: This systematic review analyzes recent advances in HI based on CT or PET/CT for tumor diagnosis and treatment, evaluating its clinical utility and limitations.
METHODS: Literatures were systematically searched in PubMed, Embase, Web of Science, and Cochrane Library. Study quality was assessed using the radiomics quality score (RQS).
RESULTS: A total of 21 studies comprising 7363 patients were included. The number of radiomic features extracted ranged from 41 to 12,838 across studies. Cancer types included lung (47.6%), head and neck (14.3%), renal (14.3%), gastrointestinal (9.5%), ovarian (9.5%), and liver (4.8%). All included studies were retrospective in design. The mean RQS was 15.71 ± 3.06. Common limitations included the absence of scanner simulation studies, prospective validation, cost-effectiveness analyses, and data/code sharing. Furthermore, substantial heterogeneity was observed across studies in terms of image acquisition, segmentation methods, and habitat definitions.
CONCLUSION: HI based on CT or PET/CT demonstrates preliminary potential in evaluating treatment response, predicting prognosis, and revealing tumor pathological and molecular characteristics. However, the current evidence is of low-to-moderate quality with a risk of bias, and considerable methodological heterogeneity exists. The overall body of evidence remains at a relatively early stage. Prospective studies are needed to validate HI as a clinical biomarker.
引用
- Chen, Ren, Peng, et al. Application advances of habitat imaging based on CT or PET/CT: a systematic review. Radiol Med. 2026. PMID: 42789168. doi:10.1007/s11547-026-02292-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。